Sun Pharma Advanced Research Company Limited (Scrip Code: NSE: SPARC; BSE: 532872) has announced that it has come to its knowledge that a complaint has been filed by Abraxis Biosciences LLC in the U.S. District Court for the District of New Jersey, which alleges that SPARC's filing of New Drug Application (NDA) for Taclantis® injection (Paclitaxel Injection Concentrate for Suspension) is an act of infringement of the Orange Book listed patents for Abraxane®.
SPARC believes that this lawsuit is without merit and will vigorously defend against these allegations.
Shares of SUN PHARMA ADVANCED RESEARCH COMPANY LTD. was last trading in BSE at Rs.154.2 as compared to the previous close of Rs. 158.7. The total number of shares traded during the day was 53929 in over 1160 trades.
The stock hit an intraday high of Rs. 158.95 and intraday low of 152.75. The net turnover during the day was Rs. 8355503.